9:00 - 12:30
9:00-13:00: first ETS council meeting
9:15-10:00: President’s Award Lecture, awarded by Nicola Powles Glover, ETS Past President: “The life and times of a reproduction toxicologist September 1979 -2019” – Graham Bailey, UK
Symposium 3: Nanoparticles and development
9:00-9:40: Elsevier Award Lecture “In vitro teratogenicity testing using a 3D, embryo-like gastruloid system” – Alfonso Martinez Arias, Universidad Pompeu Fabra, Spain
Symposium 1: Clinical trials in pregnant women and children
9:00-9:40: “Developmental toxicity of manufactured nanoparticles” - Karin S. Hougaard, University of Copenhagen, Denmark
Symposium 4: Regulatory challenges in DART data interpretation 
10:00-10:40: “Clinical trials in children” Karel Allegaert, UZLeuven, Belgium
9:40-10:10: “Developmental and reproductive toxicity of Multi-Walled Carbon Nanotubes (MWCNT)” - Jason Manton, UK
9:40-10:20: “Challenges and uncertainties in DART hazard identification of chemicals: a assessor's view“- Alberto Mantovani, Istituta Superiore di Sanita, Italy
10:40-11:10: COFFEE BREAK
10:10-10:40: COFFEE BREAK
10:20-10:50: COFFEE BREAK
11:10-11:50: “Pharmacology research in pregnancy: focus on HIV” – Angela Colbers, Radboud UMC, The Netherlands
10:40-11:20: "Unraveling developmental toxicity mechanisms of nanoparticles: The key role of the placenta" - Tina Buerki-Thurnherr, Empa, Switzerland
10:50-11:30: “Challenges in Reproductive and Development Data Interpretation” – Stephanie Cliub, Charles River, UK
11:20-12:30: 4 free communications (TBD)
11:30-12:10: “Use of New Approach Methodologies (NAMs) and Next Generation Risk Assessment (NGRA) for DART” – Kathryn Wolton, Unilever, UK
11:50-12:30: “Nonclinical considerations for Inclusion of pregnant women in clinical trials” - Kary Thompson, Janssen Research, US
12:10-12:15 Farewell Address
12:30 - 13:30


13:30 - …
Education course on Reproductive system
Symposium 2: Neurobehavioral effects on Development
13:30-14:30: ETS/BDRP exchange lecture “Read-across for DART” – Jason Manton, UK – George Daston, Procter & Gamble Company, US
13:00-14:00: 2nd council meeting
14:00-14:15: Introduction – Nicola Powles-Glover, AstraZeneca, UK
13:30-14:10: “Behavior as an endpoint in chemical neurotoxicity testing” – Harm J. Heusinkveld, RIVM, The Netherlands
14:30-16:00: 6 free communications (TBD)

14:15-15:00: “Development of the male and female reproductive organs” – Steven Van Cruchten, University of Antwerp, Belgium
14:10-14:50: “Title to be confirmed” Marta Barenys Espaler, Universidad de Barcelona, Spain
16:00-18:00: AGM

15:00-15:45: “Ovarian toxicity testing” – Agnes Stefansdottir University of Edinburgh, UK
14:50-15:30: “Zebrafish document as a potential addition to the OECD Guidance on DNT-IVB” – Arantza Muriana, BBD BioPhenix, Spain

15:45-16:15: COFFEE BREAK
15:30-16:00: COFFEE BREAK

16:15-17:00: ”Testicular toxicity testing” - TBD
16:00-17:00: 4 free communications (TBD)
 17:00-19:00: Poster session (TBD)

18:00: Welcome reception City Hall Antwerp
19:30: Conference Dinner